Table 1.
Total N (%) | No. of resistant mutations | Resistance rate (%) | ||
---|---|---|---|---|
Total |
299 |
(100) |
13 |
4.5 |
Gender |
|
|
|
|
Male |
168 |
(56.2) |
7 |
4.3 |
Female |
131 |
(43.8) |
6 |
4.8 |
Age |
|
|
|
|
≤25 |
75 |
(25.1) |
3 |
4.2 |
26-35 |
130 |
(43.5) |
6 |
4.8 |
36-45 |
58 |
(19.4) |
4 |
7.4 |
>45 |
36 |
(12.0) |
0 |
0 |
Transmission routes |
|
|
|
|
Heterosexual |
227 |
(75.9) |
8 |
3.7 |
Intravenous drug injection |
52 |
(17.4) |
5 |
10.6 |
Homosexual |
2 |
(0.7) |
0 |
0 |
Mother to child |
4 |
(1.3) |
0 |
0 |
Unknown |
14 |
(4.7) |
0 |
0 |
Ethnicity |
|
|
|
|
Han |
122 |
(40.8) |
3 |
2.5 |
Jingpo |
98 |
(32.8) |
7 |
7.7 |
Dai |
64 |
(21.4) |
2 |
3.2 |
Others |
15 |
(5.0) |
1 |
7.1 |
CD4+Count (cells/μl) |
|
|
|
|
≤200 |
21 |
(7.0) |
1 |
5.0 |
201-350 |
64 |
(21.4) |
3 |
4.9 |
351-500 |
88 |
(29.4) |
4 |
4.8 |
≥501 |
126 |
(42.1) |
5 |
4.1 |
HIV-1 Subtype |
|
|
|
|
C |
129 |
(43.1) |
7 |
5.7 |
URFs |
55 |
(18.4) |
2 |
3.8 |
CRF01_AE |
53 |
(17.7) |
1 |
1.9 |
B |
32 |
(10.7) |
2 |
6.7 |
CRF08_BC |
25 |
(8.4) |
1 |
4.2 |
CRF07_BC | 5 | (1.7) | 0 | 0.0 |
Abbriviations: URFs, unique recombinant forms; CRFs, circulating recombinant forms.